5VM
5AM Venture Management Portfolio holdings
AUM
$260M
1-Year Return
3.76%
This Quarter Return
+8.58%
1 Year Return
+3.76%
3 Year Return
+144.87%
5 Year Return
+32.61%
10 Year Return
–
AUM
$391M
AUM Growth
+$18.9M
(+5.1%)
Cap. Flow
+$61.9M
Cap. Flow
% of AUM
15.82%
Top 10 Holdings %
Top 10 Hldgs %
80.82%
Holding
26
New
5
Increased
1
Reduced
5
Closed
2
Top Buys
| 1 |
Enliven Therapeutics
ELVN
|
$127M |
| 2 |
FibroGen
FGEN
|
$6.6M |
| 3 |
Viking Therapeutics
VKTX
|
$5.83M |
| 4 |
SPRB
Spruce Biosciences, Inc. Common Stock
SPRB
|
$5.22M |
| 5 |
Mersana Therapeutics
MRSN
|
$4.87M |
Top Sells
| 1 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$60.7M |
| 2 |
scPharmaceuticals
SCPH
|
$13.9M |
| 3 |
Janux Therapeutics
JANX
|
$5.88M |
| 4 |
IDEAYA Biosciences
IDYA
|
$4.5M |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$2.43M |
Sector Composition
| 1 | Healthcare | 100% |